Clinical trial

64Cu-GRIP B in Patients With Advanced Malignancies

NCT05888532

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2023-05-25

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2023-05-25Date precision: day

Registry last updated2026-03-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Renal Cancerunresolved

Urethral Cancerunresolved

Advanced Solid Tumorunresolved

Metastatic Castration-resistant Prostate Cancerunresolved

Solid Tumor, Adultunresolved

Interventions

Copper-64 labeled Granzyme B (64Cu-GRIP B)DRUG

Positron Emission Tomography (PET)PROCEDURE

Sponsors & collaborators

Rahul Aggarwallead sponsor

National Cancer Institute (NCI)collaborator

U.S. Army Medical Research Acquisition Activitycollaborator

Mapped research locations

San FranciscoCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05888532 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.